Selegilina: farmacocinética e aspetos clínicos

Authors

  • Nuno Alexandre de Jesus Henriques TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.

DOI:

https://doi.org/10.51126/revsalus.v4iSup.273

Keywords:

selegilina, doença de Parkinson (DP), donoamina oxidase B (MAO-B), dopamina

Downloads

Download data is not yet available.

Downloads

Published

2022-04-06

Conference Proceedings Volume

Vol. 4 No. Sup (2022): Suplemento da RevSALUS - Revista Científica Internacional da RACS

Section

Posters

License

Copyright (c) 2022 RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:
Share — copy and redistribute the material in any medium or format;
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

How to Cite

Selegilina: farmacocinética e aspetos clínicos. (2022). RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone, 4(Sup), 53. https://doi.org/10.51126/revsalus.v4iSup.273